How many insider declarations has PF Equity Holdings 2 B.V. filed?

PF Equity Holdings 2 B.V. has filed 1 public insider declaration with SEC (Form 4).

What is PF Equity Holdings 2 B.V.'s role?

PF Equity Holdings 2 B.V.'s reported role is not specified by the regulator across the filings.

Which companies does PF Equity Holdings 2 B.V. report trades for?

PF Equity Holdings 2 B.V. reports trades for Allogene Therapeutics, Inc..

← Executives ★ Sign in to follow

PF Equity Holdings 2 B.V.

Other

US·SEC (Form 4)

Allogene Therapeutics, Inc.

Total declarations

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the detailed record of transactions filed by PF Equity Holdings 2 B.V.. Director active across 1 company, notably Allogene Therapeutics, Inc.. Aggregated, 1 disclosures have been logged. Activity tracked since 31 March 2022. The latest transaction was filed on 31 March 2022 (J). Regulator: SEC (Form 4). All data is free.

Declarations1 total

●

PF Equity Holdings 2 B.V.

Executives31 Mar 2022Allogene Therapeutics, Inc.

8SEC ↗

22,032,040 shares0Common StockSEC:0001883111-22-000001:0

1 of 1 declaration

InsidersTradesSigma

PF Equity Holdings 2 B.V.

Related entities

PF Equity Holdings 2 B.V.

Related entities